EGFR and non-small cell lung carcinoma: In epidermal growth factor receptor (EGFR)-wild-type non-small cell lung cancer (NSCLC), stratification based on glycolytic and cholesterol-related gene expression levels highlights a subgroup of tumors with significant enrichment of cholesterol gene signatures.